| Paraherquamides, brevianamides, and asperparalines: laboratory synthesis and biosynthesis. An interim report RM Williams, RJ Cox Accounts of chemical research 36 (2), 127-139, 2003 | 559 | 2003 |
| Asymmetric, stereocontrolled total synthesis of paraherquamide A RM Williams, J Cao, H Tsujishima, RJ Cox Journal of the American Chemical Society 125 (40), 12172-12178, 2003 | 168 | 2003 |
| Small Molecule CXCR3 Antagonists SP Andrews, RJ Cox Journal of medicinal chemistry 59 (7), 2894-2917, 2015 | 58 | 2015 |
| Discovery of highly isoform selective orally bioavailable phosphoinositide 3-kinase (PI3K)-γ inhibitors N Pemberton, M Mogemark, S Arlbrandt, P Bold, RJ Cox, C Gardelli, ... Journal of medicinal chemistry 61 (12), 5435-5441, 2018 | 44 | 2018 |
| The first synthesis of the ABC-ring system of'upenamide JP Schmidt, S Beltrán-Rodil, RJ Cox, GD McAllister, M Reid, RJK Taylor Organic letters 9 (20), 4041-4044, 2007 | 42 | 2007 |
| Reinvestigation of the dimerisation process forming isoglaucanic acid JE Baldwin, A Beyeler, RJ Cox, C Keats, GJ Pritchard, RM Adlington, ... Tetrahedron 55 (23), 7363-7374, 1999 | 42 | 1999 |
| Efficacious inhaled PDE4 inhibitors with low emetic potential and long duration of action for the treatment of COPD C De Savi, RJ Cox, DJ Warner, AR Cook, MR Dickinson, A McDonough, ... Journal of medicinal chemistry 57 (11), 4661-4676, 2014 | 32 | 2014 |
| A rapid entry to natural and unnatural disubstituted maleic anhydrides RM Adlington, JE Baldwin, RJ Cox, GJ Pritchard Synlett 2002 (05), 0820-0822, 2002 | 25 | 2002 |
| Plasma protein binding as an optimisable parameter for acidic drugs P Gardiner, RJ Cox, K Grime Drug Metabolism and Disposition, dmd. 119.087163, 2019 | 24 | 2019 |
| Synthetic studies towards paraherquamide F: synthesis of the 1, 7-dihydropyrano [2, 3-g] indole ring system RJ Cox, RM Williams Tetrahedron letters 43 (12), 2149-2152, 2002 | 23 | 2002 |
| Deacetalisation–bicyclisation routes to novel polycyclic heterocycles using stannous chloride dihydrate AN Cayley, RJ Cox, C Ménard-Moyon, JP Schmidt, RJK Taylor Tetrahedron Letters 48 (37), 6556-6560, 2007 | 19 | 2007 |
| Towards a Biomimetic Synthesis of the Marine Alkaloids Papuamine and Haliclonadiamine: Model Studies RM Adlington, JE Baldwin, GL Challis, RJ Cox, GJ Pritchard Tetrahedron 56 (4), 623-628, 2000 | 16 | 2000 |
| Discovery and evaluation of a novel monocyclic series of CXCR2 antagonists RP Austin, C Bennion, RV Bonnert, L Cheema, AR Cook, RJ Cox, ... Bioorganic & medicinal chemistry letters 25 (7), 1616-1620, 2015 | 15 | 2015 |
| Pyrimidine sulphonamide derivatives as chemokine receptor modulators DR Cheshire, RJ Cox, P Meghani, JP Stonehouse US Patent 7,838,675, 2010 | 14* | 2010 |
| Phenethanolamine derivatives as beta2 adrenoreceptor agonists L Alcaraz, A Bailey, R Cox, P Meghani, G Pairaudeau, M Stocks US Patent App. 12/282,019, 2009 | 14 | 2009 |
| Cepaea nemoralis (L.) in Göteborg, S.W. Sweden: variation in a recent urban invader RAD Cameron, RJ Cox, T Von Proschwitz, M Horsák Folia Malacologica 22 (3), 169-182, 2014 | 9 | 2014 |
| Pyrimidine sulphonamide derivatives as chemokine receptor modulators DR Cheshire, RJ Cox, P Meghani, NM Smith, JP Stonehouse, CF Preston US Patent 8,410,123, 2013 | 7 | 2013 |
| Chemical Compounds 637: Pyridopyrimidinediones as PDE4 Inhibitors RV Bonnert, F Burkamp, RJ Cox, S De Sousa, M Dickinson, SF Hunt, ... US Patent App. 12/522,782, 2010 | 7* | 2010 |
| Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators DR Cheshire, RJ Cox, P Meghani, NM Smith, JP Stonehouse, CF Preston US Patent App. 13/620,075, 2013 | 6 | 2013 |
| Chemical Compounds 293 G Andrews, RJ Cox, C De Savi, P Meghani, HJ Sanganee, DJ Warner US Patent App. 12/471,599, 2010 | 4 | 2010 |
